Xenetic Biosciences's market cap is currently $4.78M. The company's EPS TTM is $-0.45; its P/E ratio is ―; Xenetic Biosciences is scheduled to report earnings on August 13, 2025, and the estimated EPS forecast is $-0.49. See an overview of income statement, balance sheet, and cash flow financials.
